Document Detail

Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
MedLine Citation:
PMID:  6403267     Owner:  NLM     Status:  MEDLINE    
Tocainide, an oral analog of lidocaine, was evaluated as a long-term antiarrhythmic agent in 21 patients with symptomatic complex ventricular ectopic activity (10 with hemodynamically significant ventricular tachycardia) refractory to currently available antiarrhythmics singly, and in combination for periods of 3 days to 35 months (mean 13.6 months). Tocainide appeared to be an effective and safe agent for the control of these refractory symptomatic ventricular arrhythmias in 14 of the 21 patients (66%). Minor central nervous system and gastrointestinal side effects were present in most of the patients, usually early on in therapy, and only precluded long-term use in 2 patients. Furthermore, lidocaine responsiveness was a good predictor of tocainide effectiveness in this group of patients. Tocainide precipitated atrioventricular (A-V) block in one patient with pre-existing A-V nodal disease; two patients developed a skin rash while on tocainide therapy. These two patients had previously developed lupus-like syndromes and skin rashes while on procainamide. The ANA titers had been falling in these two patients while on tocainide, and in one of these patients with true systemic lupus erythematosus, rechallenge with tocainide failed to produce skin rash. Tocainide's long plasma half-life and high oral bioavailability permit an 8-h regime. We conclude that tocainide is an effective, safe antiarrhythmic agent with tolerable side effects.
C I Haffajee; G M Sacks; J S Alpert; J P Howe; I S Ockene; J A Paraskos; J E Dalen
Related Documents :
16374557 - Score indices for predicting electrophysiologic outcomes in patients with unexplained s...
3607587 - Pindolol therapy for bradycardia/tachycardia syndrome.
1992697 - Continuous electrocardiographic monitoring in hypertensive crises in pregnancy.
2793267 - Electrophysiologic evaluation of patients with hypertrophic cardiomyopathy.
24453677 - Tomographic correlation for magerl's technique in c1-c2 arthrodesis in children.
9604997 - The value of cyfra 21-1, a new tumor marker, in nasopharyngeal carcinoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  6     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1983 Feb 
Date Detail:
Created Date:  1983-05-27     Completed Date:  1983-05-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  72-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arrhythmias, Cardiac / drug therapy*
Drug Administration Schedule
Heart Ventricles
Lidocaine / administration & dosage,  adverse effects,  analogs & derivatives*,  therapeutic use
Middle Aged
Reg. No./Substance:
137-58-6/Lidocaine; 41708-72-9/Tocainide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Separation of two molecular species of the Sm antigen by affinity chromatography with murine monoclo...
Next Document:  Assessment of liver function by the aminopyrine breath test.